Biodesix Inc. (BDSX)
NASDAQ: BDSX
· Real-Time Price · USD
7.75
-0.26 (-3.19%)
At close: Sep 26, 2025, 3:59 PM
7.74
-0.13%
Pre-market: Sep 29, 2025, 05:50 AM EDT
Biodesix Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Development Services Revenue | 2.12M | 1.64M | 17.17M | 16.54M | 13.8M | 12.8M | 12.3M | 11.45M | 8.64M | 8.26M | 10.44M | 10.21M | 5.63M | 5.87M | 5.04M | 10.84M | 27.2M | 32.37M | 8.55M |
| Development Services Revenue Growth | +29.11% | -90.44% | +3.80% | +19.88% | +7.81% | +4.03% | +7.44% | +32.43% | +4.71% | -20.94% | +2.32% | +81.18% | -3.96% | +16.39% | -53.51% | -60.15% | -15.98% | +278.47% | n/a |
| Diagnostic Tests Revenue | 17.9M | 16.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Diagnostic Tests Revenue Growth | +9.70% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 22.41M | 20.45M | 20.22M | 20.02M | 19.66M | 20.56M | 16.25M | 15.5M | 16.65M | 18.99M | 16.63M | 15.11M | 15.23M | 14.49M | 13.56M | 13.61M | 11.43M | 11.93M | 12.06M | 7.88M | 6.83M | 8.08M | 6.56M | 8.21M | 7.93M | 7.93M | 6.47M | 6.47M |
| Selling, General, and Administrative Revenue Growth | +9.60% | +1.13% | +1.01% | +1.81% | -4.36% | +26.49% | +4.87% | -6.94% | -12.31% | +14.21% | +10.00% | -0.79% | +5.16% | +6.85% | -0.36% | +19.10% | -4.21% | -1.14% | +53.12% | +15.29% | -15.42% | +23.23% | -20.15% | +3.50% | 0.00% | +22.54% | 0.00% | n/a |
| Research and Development Revenue | 3.27M | 2.87M | 2.41M | 2.55M | 2.56M | 2.04M | 1.89M | 1.94M | 2.91M | 3.25M | 3.56M | 2.97M | 3.36M | 3.21M | 2.85M | 3.29M | 3.32M | 3.32M | 3.1M | 2.71M | 2.11M | 2.9M | 2.5M | 2.36M | 2.8M | 2.8M | 2.05M | 2.05M |
| Research and Development Revenue Growth | +13.90% | +18.89% | -5.22% | -0.43% | +25.39% | +7.99% | -2.53% | -33.40% | -10.49% | -8.81% | +20.03% | -11.63% | +4.83% | +12.41% | -13.39% | -0.90% | +0.06% | +6.96% | +14.75% | +28.43% | -27.34% | +15.91% | +6.06% | -15.86% | 0.00% | +36.96% | 0.00% | n/a |